1) p16 gene
p16 基因
1.
Objective:To explore if there is any difference on aberrant methylationstatus of p16 gene between in the serum and in the tissue of colorectal cancer, andto study the association of the aberrant methylation status of p16 gene with someclinical factors, including tumor size, histologic types, degree of differentiation,Dukeχs stage, lymph node metastasis and family history.
目的: 探讨结直肠癌组织和血清中 p16 基因的异常甲基化状态是否存在差异;结直肠癌患者血清中 p16 基因异常甲基化状态与肿瘤大小、组织学分类、分化程度、Dukeχs 分期、淋巴结转移及家族史等临床因素的关系。
2) p16 gene
P16基因
1.
Research of expression of p16 gene in K562/A02 cell line;
p16基因在K562/A02细胞株表达情况的研究
2.
Antitumor efficacy of the adenoviral vector expressing p16 gene targeting the hepatocellular carcinoma models on nude mice;
靶向肝癌表达p16基因的腺病毒载体对裸鼠移植瘤的抗癌活性
3.
The clinical significance of C-myc and P16 gene s expression in hepatocellular carcinoma;
C-myc基因和P16基因在肝细胞癌中的表达及其临床意义
3) p16
p16基因
1.
Detection of methylation of p16 gene by nested methylation specific polymerase chain reaction;
巢式甲基化特异性PCR检测p16基因甲基化
2.
Correlation of p16 hypermethylation with tumorigenesis and the development of gastric cancer;
p16基因高甲基化在胃癌发展中的作用
3.
Effects of exogenous p16 gene on the cell cycle and growth of renal carcinoma cell;
外源性p16基因对肾癌细胞周期及体外增殖的影响
4) CDKN2/P16 gene
CDKN2/P16基因
1.
Analysis on point mutation of the CDKN2/p16 gene in lung cancer;
肺癌组织CDKN2/p16基因点突变的分析
2.
Study on the existence state of CDKN2/p16 gene in human primary malignant tumors;
CDKN2/p16基因在四种原发恶性肿瘤中存在状态的研究
6) pl6 gene
p16基因
1.
Objective: To study the genetic alterations of pl6 gene in primary hepatocellular carcinoma.
结果84例肝癌标本中p16基因第1外显子缺失9例,第2外显子缺失23例,其中有3例第1、2外显子共同缺失,总缺失率为34。
2.
Objective: To explore if there is any difference on aberrant methylation status of pl6 gene between in the serum and in the tissue of colorectal cancer, and to study the association of the aberrant methylation status of p16 gene with some clinical factors, including tumor size, histologic types, degree of differentiation, Duke s stage, lymph node metastasis and family history.
目的: 探讨结直肠癌组织和血清中p16基因的异常甲基化状态是否存在差异;结直肠癌患者血清中p16基因异常甲基化状态与肿瘤大小、组织学分类、分化程度、Duke’s分期、淋巴结转移及家族史等临床因素的关系。
补充资料:(16-alpha,17-beta)-estra-1,3,5(10)-triene-3,16,17-triol
CAS:50-27-1
分子式:C18H24O3
分子质量:288.38
熔点:281-282℃
中文名称:雌三醇;16,17-二羟甾醇
英文名称:(16-alpha,17-beta)-estra-1,3,5(10)-triene-3,16,17-triol
(16-alpha,17-beta)-oestra-1,3,5(10)-triene-3,16,17-triol
1,3,5-estratriene-3-beta,16-alpha,17-beta-triol
1,3,5-oestratriene-3-beta,16-alpha,17-beta-triol
16-alpha,17-beta-estriol
16-alpha,17-beta-oestriol
用途:治疗白细胞减少症,对前列腺肥大、前列腺癌也有一定疗效。
分子式:C18H24O3
分子质量:288.38
熔点:281-282℃
中文名称:雌三醇;16,17-二羟甾醇
英文名称:(16-alpha,17-beta)-estra-1,3,5(10)-triene-3,16,17-triol
(16-alpha,17-beta)-oestra-1,3,5(10)-triene-3,16,17-triol
1,3,5-estratriene-3-beta,16-alpha,17-beta-triol
1,3,5-oestratriene-3-beta,16-alpha,17-beta-triol
16-alpha,17-beta-estriol
16-alpha,17-beta-oestriol
用途:治疗白细胞减少症,对前列腺肥大、前列腺癌也有一定疗效。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条